Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Qazilbash is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
University of ConnecticutResidency, Internal Medicine, 1991 - 1992
Wright State UniversityResidency, Internal Medicine, 1989 - 1991
Dow University of Health SciencesClass of 1987
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
TX State Medical License 2002 - 2028
OK State Medical License 2020 - 2027
TN State Medical License 2023 - 2027
AL State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
American Board of Internal Medicine Hematology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
- Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome Start of enrollment: 1999 Dec 01
- Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients Start of enrollment: 2006 Jun 01
- FM 140 vs FM100 Study in Patients With Multiple Myeloma Start of enrollment: 2002 Jan 01
Publications & Presentations
PubMed
- D-VRD induction and autologous transplant in patients ≥70 years.Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Mark R Tanner, Muhammad Bilal Islam
Blood Cancer Journal. 2026-06-05 - A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.Hans C Lee, Melody R Becnel, Lei Feng, Oren Pasvolsky, Astrid Murga
American Journal of Hematology. 2026-06-01 - Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients.Christen M Dillard, Ashwath Gurumurthi, Hans C Lee, Sheeba K Thomas, Donna M Weber
Clinical Lymphoma, Myeloma & Leukemia. 2026-05-01
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
- Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
Abstracts/Posters
- Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical TrialMuzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell TransplantationMuzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Authored Content
- Highlights of ASH 2024: Focus on Multiple MyelomaDecember 2024
- ASH 2020: What’s New in Stem Cell Transplant and Cellular Therapy in Multiple Myeloma?December 2020
Press Mentions
Multiple Myeloma and Spine Cancer Survivor: ‘Always Think About a Second Opinion’September 23rd, 2024- Medical Laboratory Scientist Faces Her Own Multiple Myeloma DiagnosisJuly 15th, 2022
- Immunotherapies Target Multiple MyelomaNovember 25th, 2020
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
